Authors:
Cherpelis, S
Jin, X
Gettie, A
Ho, DD
Barnett, SW
Shrivastava, I
Stamatatos, L
Citation: S. Cherpelis et al., DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques, IMMUNOL LET, 79(1-2), 2001, pp. 47-55
Authors:
Strizki, JM
Xu, S
Wagner, NE
Wojcik, L
Liu, J
Hou, Y
Endres, M
Palani, A
Shapiro, S
Clader, JW
Greenlee, WJ
Tagat, JR
McCombie, S
Cox, K
Fawzi, AB
Chou, CC
Pugliese-Sivo, C
Davies, L
Moreno, ME
Ho, DD
Trkola, A
Stoddart, CA
Moore, JP
Reyes, GR
Baroudy, BM
Citation: Jm. Strizki et al., SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo, P NAS US, 98(22), 2001, pp. 12718-12723
Authors:
Foster, JL
Molina, RP
Luo, T
Arora, VK
Huang, YX
Ho, DD
Garcia, JV
Citation: Jl. Foster et al., Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates, J VIROLOGY, 75(4), 2001, pp. 1672-1680
Authors:
Cherpelis, S
Shrivastava, I
Gettie, A
Jin, X
Ho, DD
Barnett, SW
Stamatatos, L
Citation: S. Cherpelis et al., DNA vaccination with the human immunodeficiency virus type 1 SF162 Delta V2 envelope elicits immune responses that offer partial protection from simian/human immunodeficiency virus infection to CD8(+) T-cell-depleted rhesus macaques, J VIROLOGY, 75(3), 2001, pp. 1547-1550
Authors:
Zhang, LQ
He, T
Talal, A
Wang, G
Frankel, SS
Ho, DD
Citation: Lq. Zhang et al., In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5 (vol 72, pg 5035, 1998), J VIROLOGY, 75(2), 2001, pp. 1091-1091
Authors:
Mohri, H
Perelson, AS
Tung, K
Ribeiro, RM
Ramratnam, B
Markowitz, M
Kost, R
Hurley, A
Weinberger, L
Cesar, D
Hellerstein, MK
Ho, DD
Citation: H. Mohri et al., Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy, J EXP MED, 194(9), 2001, pp. 1277-1287
Authors:
Ramratnam, B
Mittler, JE
Zhang, LQ
Boden, D
Hurley, A
Fang, F
Macken, CA
Perelson, AS
Markowitz, M
Ho, DD
Citation: B. Ramratnam et al., The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy, NAT MED, 6(1), 2000, pp. 82-85
Authors:
Jin, X
Ogg, G
Bonhoeffer, S
Safrit, J
Vesanen, M
Bauer, D
Chen, D
Cao, YZ
Demoitie, MA
Zhang, LQ
Markowitz, M
Nixon, D
McMichael, A
Ho, DD
Citation: X. Jin et al., An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes, MOL MED, 6(9), 2000, pp. 803-809
Authors:
Chakrabarti, LA
Lewin, SR
Zhang, LQ
Gettie, A
Luckay, A
Martin, LN
Skulsky, E
Ho, DD
Cheng-Mayer, C
Marx, PA
Citation: La. Chakrabarti et al., Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection, J VIROLOGY, 74(3), 2000, pp. 1209-1223
Authors:
Chen, ZW
Huang, YX
Zhao, XQ
Skulsky, E
Lin, D
Ip, J
Gettie, A
Ho, DD
Citation: Zw. Chen et al., Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serialpassages in pig-tailed macaques (Macaca nemestrina), J VIROLOGY, 74(14), 2000, pp. 6501-6510
Authors:
Metzner, KJ
Jin, X
Lee, FV
Gettie, A
Bauer, DE
Di Mascio, M
Perelson, AS
Marx, PA
Ho, DD
Kostrikis, LG
Connor, RI
Citation: Kj. Metzner et al., Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine, J EXP MED, 191(11), 2000, pp. 1921-1931
Authors:
Zhang, LQ
Chung, C
Hu, BS
He, T
Guo, Y
Kim, AJ
Skulsky, E
Jin, X
Hurley, A
Ramratnam, B
Markowitz, M
Ho, DD
Citation: Lq. Zhang et al., Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy, J CLIN INV, 106(7), 2000, pp. 839-845
Authors:
Nixon, DF
Douek, D
Kuebler, PJ
Jin, X
Vesanen, M
Bonhoeffer, S
Cao, YZ
Koup, RA
Ho, DD
Markowitz, M
Citation: Df. Nixon et al., Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA butnot mRNA following early combination antiretroviral therapy, IMMUNOL LET, 66(1-3), 1999, pp. 219-228
Authors:
Ramratnam, B
Bonhoeffer, S
Binley, J
Hurley, A
Zhang, LQ
Mittler, JE
Markowitz, M
Moore, JP
Perelson, AS
Ho, DD
Citation: B. Ramratnam et al., Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis, LANCET, 354(9192), 1999, pp. 1782-1785
Authors:
Zhang, LQ
Ramratnam, B
Tenner-Racz, K
He, YX
Vesanen, M
Lewin, S
Talal, A
Racz, P
Perelson, AS
Korber, BT
Markowitz, M
Ho, DD
Citation: Lq. Zhang et al., Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy, N ENG J MED, 340(21), 1999, pp. 1605-1613
Authors:
Lewin, SR
Vesanen, M
Kostrikis, L
Hurley, A
Duran, M
Zhang, L
Ho, DD
Markowitz, M
Citation: Sr. Lewin et al., Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1 infected individuals on prolonged effective antiretroviral therapy, J VIROLOGY, 73(7), 1999, pp. 6099-6103
Authors:
Kostrikis, LG
Neumann, AU
Thomson, B
Korber, BT
McHardy, P
Karanicolas, R
Deutsch, L
Huang, YX
Lew, JF
McIntosh, K
Pollack, H
Borkowsky, W
Spiegel, HML
Palumbo, P
Oleske, J
Bardeguez, A
Luzuriaga, K
Sullivan, J
Wolinsky, SM
Koup, RA
Ho, DD
Moore, JP
Citation: Lg. Kostrikis et al., A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants, J VIROLOGY, 73(12), 1999, pp. 10264-10271
Authors:
Ogg, GS
Jin, X
Bonhoeffer, S
Moss, P
Nowak, MA
Monard, S
Segal, JP
Cao, Y
Rowland-Jones, SL
Hurley, A
Markowitz, M
Ho, DD
McMichael, AJ
Nixon, DF
Citation: Gs. Ogg et al., Decay kinetics of human immunodeficiency virus-specific effector cytotoxicT lymphocytes after combination antiretroviral therapy, J VIROLOGY, 73(1), 1999, pp. 797-800